Publication

The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study

http://www.ncbi.nlm.nih.gov/pubmed/30711064 HPTN 065 Study Details

Citation

Adamson B, El-Sadr W, Dimitrov D, Gamble T, Beauchamp G, Carlson J, Garrison L, Donnell D. The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study. Value in Health. 2019, 22: 194-202. PMC6362462

Abstract

OBJECTIVE: To evaluate the cost-effectiveness of financial incentives for human immunodeficiency virus (HIV) viral suppression compared to standard of care. STUDY DESIGN: Mathematical model of 2-year intervention offering financial incentives ($70 quarterly) for viral suppression (